Lindus Health

Overview

Lindus Health is a technology-enabled clinical research organization (CRO) that positions itself as an "anti-CRO" by combining vertically integrated trial operations with proprietary software and AI-powered patient recruitment. The company specializes in accelerating clinical trial timelines through end-to-end study execution, from protocol design through data management and regulatory submission.

Core Capabilities

Trial Execution & Operations

• Completed 45+ clinical trials across diverse therapeutic areas (metabolic health, CNS, cardiovascular, rare disease)
• Proven track record: 82% of Lindus-managed trials complete enrollment on or ahead of schedule
• Average 72.9% faster enrollment compared to industry baseline
• Global execution spanning US, UK, and Europe with integrated APAC partnerships
• Phase 1–2a focus; in-licenses clinical-stage assets and develops them internally

Patient Recruitment & Retention

• Proprietary omni-channel recruitment leveraging access to 40+ million electronic medical records (EMRs) in primary care
• AI-powered EHR screening and patient pre-screening with advanced algorithms
• Central Patient Recruitment Coordinator (PRC) team managing virtual patient interactions
• Geo-targeted digital advertising, primary care network relationships, and patient advocacy partnerships
• Lindus Virtual Site for fully remote assessments; Lindus Site Network for local engagement; External Site integration for sponsor flexibility
• Fierce CRO Award winner for Outstanding Patient Recruitment and Retention

Technology Platform

• Proprietary eClinical platform (Citrus™) for centralized screening, enrollment pathway management, and real-time site capacity metrics
• AI agents for pre-screening, patient question answering, visit scheduling, and participant triage
• Real-time data access and live funnel metrics across entire patient journey
• Clinical data management (CDM) software integration with EHR systems and advanced analytics

Regulatory & Compliance

• Clinical trial application preparation and regulatory submission support
• Risk-shared, fixed-price, and milestone-based payment models
• Aligned incentives through performance-based pricing

Therapeutic Areas & Indications

Proven execution in metabolic health (type 2 diabetes, obesity), CNS (major depressive disorder), cardiovascular (hypertension), respiratory (asthma), and chronic conditions (chronic fatigue syndrome). Non-ultrarare chronic disease focus aligned with core operational capabilities.

Funding & Scale

• $80+ million total funding from investors including Balderton, Peter Thiel, Creandum, Firstminute Capital, and Seedcamp
• 120-person team across US and Europe
• Founded as technology-first CRO; expanded into asset development and in-licensing

Differentiation

Lindus Health eliminates traditional CRO handoffs by combining in-house trial design, execution, and patient recruitment under one integrated team and technology stack. The company targets faster timelines, higher enrollment quality, and adaptive trial designs not practical with standard biopharma partners.